share_log

Axsome Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Fairmount Funds Management LLC(5.0%),Peter Harwin(5.0%), etc.

Axsome Therapeutics | SC 13G:超过5%持股股东披露文件-Fairmount Funds Management LLC(5.0%),Peter Harwin(5.0%)等

SEC announcement ·  2023/07/07 16:00
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息